Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Klebsiella pneumoniae

ABSTRACT: Oxa48 like carbapenemase-producing Klebsiella pneumoniae isolated from blood of sepsis patients admitted to tertiary care hospitals in kolkata,India.

PROVIDER: PRJNA723764 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR14407134_1.fastq.gz	Fastqsanger.gz
	SRR19090382_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Klebsiella pneumoniae

Project description:Studies on WGS of Carbapenem-Resistant KPC-producing Klebsiella pneumoniae isolated from blood of sepsis patients admitted to tertiary care hospitals in Kolkata, India

| PRJNA649689 | ENA

Proteus mirabilis

Project description:Study on Carbapenem-resistant Proteus mirabilis isolated from the blood of sepsis patients admitted in tertiary care hospitals in Kolkata,India

| PRJNA662829 | ENA

Serratia ureilytica strain:FTCR59

Project description:Studies on WGS of Carbapenem Resistant Serratia sp. isolated from the blood of sepsis patients admitted to tertiary care hospitals in Kolkata, India

| PRJNA662834 | ENA

Enterobacter

Project description:Study on blood-borne Carbapenem-resistant Enterobacter cloacae complex isolated from sepsis patients admitted to ICU departments of tertiary care hospitals at Kolkata,India.

| PRJNA721536 | ENA

Whole transcriptomic analysis of mechanisms of tolerance and resistance to chlorhexidine in carbapenemase-producing Klebsiella pneumoniae clinical strains

Project description:The increasing resistence and/or bacterial tolerance to bactericides, such as chlorhexidine, causes worrisome public health problems. Using transcriptomical and microbiological studies, we analysed the molecular mechanisms associated with the adaptation to chlorhexidine in two carbapenemase-producing strains of Klebsiella pneumoniae belonging ST258-KPC3 and ST846-OXA48.

2020-03-21 | GSE147316 | GEO

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

Project description:The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization mass spectrometry (A-MALDI) method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins. Enhancements were made to improve detectability and mass accuracy through the optimization of MALDI-TOF settings and internal mass calibration. A total of 581 clinical isolates were analyzed, including 469 CPE isolates (388 KPC, 51 NDM, 40 OXA, and 2 GES) and 112 carbapenemase-negative isolates. Clinical evaluation of the A-MALDI demonstrated 100% accuracy and precision in identifying all the collected CPE isolates. Additionally, A-MALDI successfully discriminated individual carbapenemase subtypes (KPC-2 or KPC-3/4; OXA-48 or OXA-181 or OXA-232; GES-5 or GES-24) and also differentiated co-producing carbapenemase strains (KPC & NDM; KPC & OXA; KPC & GES; NDM & OXA), attributed to its high mass accuracy and simultaneous detection capability. A-MALDI is considered a valuable diagnostic tool for accurately identifying CPE and carbapenemase’s subtypes in clinical isolates. It may also aid in selecting appropriate antibiotics for each carbapenemase subtype. Ultimately, we expect that the A-MALDI method will contribute to preventing the spread of antibiotic resistance and improving human public health.

2024-11-25 | PXD046179 | Pride

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

2024-11-26 | PXD058284 | Pride

Genomic landscape of the individual host response and outcomes in severe sepsis revealed by transcriptomic profiling and quantitative trait mapping (derivation cohort)

Project description:We assayed leukocyte global gene expression for a prospective discovery cohort of 265 adult patients admitted to UK intensive care units with severe sepsis due to community acquired pneumonia.

2016-02-25 | E-MTAB-4421 | biostudies-arrayexpress

Genomic landscape of the individual host response and outcomes in severe sepsis revealed by transcriptomic profiling and quantitative trait mapping (validation cohort)

Project description:We assayed leukocyte global gene expression for a prospective validation cohort of 106 adult patients admitted to UK intensive care units with severe sepsis due to community acquired pneumonia.

2016-02-25 | E-MTAB-4451 | biostudies-arrayexpress

Microarray transcriptomic profiling of patients with sepsis due to faecal peritonitis and pneumonia to identify shared and distinct aspects of the transcriptomic response (validation cohort)

Project description:We assayed leukocyte global gene expression for a prospective discovery cohort of 106 adult patients admitted to UK intensive care units with sepsis due to community acquired pneumonia or faecal peritonitis. We assigned all samples to sepsis response signature groups after performing unsupervised analysis of the transcriptomic data.

2017-05-01 | E-MTAB-5274 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data